Eli Lilly says it plans to submit its trial results to the U.S. Food and Drug Admin to possibly expand Zepbound’s use for obstructive sleep apnea.
Eli Lilly says it plans to submit its trial results to the U.S. Food and Drug Admin to possibly expand Zepbound’s use for obstructive sleep apnea.